762 related articles for article (PubMed ID: 15940764)
1. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
[TBL] [Abstract][Full Text] [Related]
2. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients.
Turkcapar N; Demir O; Atli T; Kopuk M; Turgay M; Kinikli G; Duman M
Arch Gerontol Geriatr; 2006; 42(2):225-31. PubMed ID: 16191448
[TBL] [Abstract][Full Text] [Related]
3. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
[TBL] [Abstract][Full Text] [Related]
4. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.
Wolfe F
J Rheumatol; 1997 Aug; 24(8):1477-85. PubMed ID: 9263138
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
Sokka T; Pincus T
J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
[TBL] [Abstract][Full Text] [Related]
9. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
[TBL] [Abstract][Full Text] [Related]
10. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis.
de Man YA; Hazes JM; van de Geijn FE; Krommenhoek C; Dolhain RJ
Arthritis Rheum; 2007 Jun; 57(5):716-22. PubMed ID: 17530669
[TBL] [Abstract][Full Text] [Related]
11. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
[TBL] [Abstract][Full Text] [Related]
12. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
Gordon P; West J; Jones H; Gibson T
J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
[TBL] [Abstract][Full Text] [Related]
13. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
[TBL] [Abstract][Full Text] [Related]
14. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate.
Yazici Y; Pincus T; Kautiainen H; Sokka T
J Rheumatol; 2004 Sep; 31(9):1723-6. PubMed ID: 15338490
[TBL] [Abstract][Full Text] [Related]
15. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis.
Yildirim K; Karatay S; Melikoglu MA; Gureser G; Ugur M; Senel K
Ann Clin Lab Sci; 2004; 34(4):423-6. PubMed ID: 15648784
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.
Emlen W; Niebur J; Flanders G; Rutledge J
J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis.
Lopez-Olivo MA; Gonzalez-Lopez L; Garcia-Gonzalez A; Villa-Manzano AI; Cota-Sanchez AR; Salazar-Paramo M; Varon-Villalpando E; Cardona-Muñoz EG; Gamez-Nava JI
Scand J Rheumatol; 2006; 35(2):112-6. PubMed ID: 16641044
[TBL] [Abstract][Full Text] [Related]
18. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis.
Dessein PH; Joffe BI; Stanwix AE
J Rheumatol; 2004 Jun; 31(6):1095-7. PubMed ID: 15170920
[TBL] [Abstract][Full Text] [Related]
20. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis.
Ertenli I; Kiraz S; Arici M; Haznedaroglu IC; Calgüneri M; Celik I; Kirazli S
J Rheumatol; 1998 Jun; 25(6):1054-8. PubMed ID: 9632062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
